These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Preparation and biological characteristics of a new doxorubicin-gelatin-microspheres for hepatic artery embolization]. Wan Y; Ma Y; Chen XL; Duan LG; Luo DH; Xia CQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):119-24. PubMed ID: 21355316 [TBL] [Abstract][Full Text] [Related]
27. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma. Kallini JR; Gabr A; Salem R; Lewandowski RJ Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186 [TBL] [Abstract][Full Text] [Related]
28. Integrated use of Filippi L; Evangelista L; Schillaci O Expert Rev Gastroenterol Hepatol; 2023; 17(6):531-538. PubMed ID: 37194803 [TBL] [Abstract][Full Text] [Related]
29. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. Teyateeti A; Mahvash A; Long J; Abdelsalam M; Avritscher R; Kaseb A; Odisio B; Ravizzini G; Surasi D; Teyateeti A; Macapinlac H; Kappadath SC World J Gastroenterol; 2021 Dec; 27(47):8166-8181. PubMed ID: 35068861 [TBL] [Abstract][Full Text] [Related]
30. Radioembolization for the treatment of hepatocellular carcinoma. Kim HC Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530 [TBL] [Abstract][Full Text] [Related]
31. Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives. Sacco R; Mismas V; Marceglia S; Romano A; Giacomelli L; Bertini M; Federici G; Metrangolo S; Parisi G; Tumino E; Bresci G; Corti A; Tredici M; Piccinno M; Giorgi L; Bartolozzi C; Bargellini I World J Gastroenterol; 2015 Jun; 21(21):6518-25. PubMed ID: 26074690 [TBL] [Abstract][Full Text] [Related]
32. Evolving Role of Radiopharmaceuticals in Hepatocellular Carcinoma Treatment. Wu L; Shen F; Xia Y; Yang YF Anticancer Agents Med Chem; 2016; 16(9):1155-65. PubMed ID: 26961314 [TBL] [Abstract][Full Text] [Related]
33. A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC. Nam JY; Lee YB; Lee JH; Yu SJ; Kim HC; Chung JW; Yoon JH; Kim YJ Dig Dis Sci; 2022 Jan; 67(1):329-336. PubMed ID: 33538921 [TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
35. Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours. Alregib AH; Tan HY; Wong YH; Kasbollah A; Wong EH; Abdullah BJJ; Perkins AC; Yeong CH J Labelled Comp Radiopharm; 2023 Aug; 66(10):308-320. PubMed ID: 37287213 [TBL] [Abstract][Full Text] [Related]
36. Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy. Wang XM; Yin ZY; Yu RX; Peng YY; Liu PG; Wu GY World J Gastroenterol; 2008 Jan; 14(4):518-23. PubMed ID: 18203282 [TBL] [Abstract][Full Text] [Related]
37. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres. Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957 [TBL] [Abstract][Full Text] [Related]
38. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574 [TBL] [Abstract][Full Text] [Related]
39. Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT. O'Connor PJ; Pasik SD; van der Bom IM; Bishay V; Radaelli A; Kim E Cardiovasc Intervent Radiol; 2020 Feb; 43(2):295-301. PubMed ID: 31578635 [TBL] [Abstract][Full Text] [Related]
40. Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study. Kolligs F; Arnold D; Golfieri R; Pech M; Peynircioglu B; Pfammatter T; Ronot M; Sangro B; Schaefer N; Maleux G; Munneke G; Pereira H; Zeka B; de Jong N; Helmberger T; JHEP Rep; 2023 Feb; 5(2):100633. PubMed ID: 36593888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]